The altered regulation of the TLR4 signalling pathway has been associated with a wide range of conditions, including sepsis, acute lung injury, acute kidney injury, rheumatoid arthritis, inflammatory bowel disease, cardiac diseases, diabetes-induced high blood pressure, pregnancy-related disorders, and complications following COVID-19 [30]. This evidence concerns the gene TLR4 and COVID-19.